Roivainen group is a part of the Health from Science programme (TERVA) of the Academy of Finland. The programme spans from 2018 to 2020.
Our project in the programme is Reprogramming of macrophage phenotypes as early predictor of cardiovascular and metabolic disease development (MAP-CAD). One of our postdocs, Senthil Palani, is already working hard on the project.
Funding decicions for the TERVA programme were made november 2017.